Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceccy: Carvedilol for Prevention of Chemotherapy-Induced Cardiotoxicity
NCT01724450Phase 3Completed
- Sponsor
- Universidade de São Paulo
- Start
- Apr 2013
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carvedilol in chemotherapy-induced cardiomyopathy (CICM), sponsored by Universidade de São Paulo. Started Apr 2013; status: completed.
02
Drugs
carvedilol
03
Conditions
chemotherapy-induced cardiomyopathy (CICM)
Beyond the preview
Go deeper on NCT01724450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01724450.